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A proportion of U.S. veterans returning from Iraq and Afghanistan have experienced mild traumatic brain injury (mTBI), which is
associated with increased risk for developing posttraumatic stress disorder (PTSD). Prolonged Exposure (PE) has proven effectiveness in
the treatment of PTSD; however, some clinicians have reservations about using PE with individuals with a history of mTBI. We examined
the impact of PE for veterans with PTSD and with or without a history of mTBI in a naturalistic sample of 51 veterans who received PE at
a Veterans Health Administration PTSD clinic. We also analyzed previously collected data from a controlled trial of 22 veterans randomly
assigned to PE or present centered therapy. For both sets of data, we found that PE reduced symptom levels and we also did not detect an
effect for mTBI, suggesting that PE may be helpful for individuals with PTSD and a history of mTBI.
Over two million individuals (Defense Manpower Data Cen-
ter, 2009) have been deployed to Iraq or Afghanistan as part of
Operation Enduring Freedom (OEF), Operation Iraqi Freedom
(OIF), and/or Operation New Dawn (OND). A small proportion
(between 10–20%; Hoge et al., 2008; Polusny et al., 2011) expe-
rience mild traumatic brain injury (mTBI). Specifically, mTBI
is (American Congress of Rehabilitation Medicine, 1993)
A traumatically induced physiological disruption of brain
function, as manifested by at least one of the following:
1. any period of loss of consciousness [not exceeding
30 minutes]; 2. any loss of memory for events immediately
before or after the accident; 3. any alteration in mental state
at the time of the accident (e.g., feeling dazed, disoriented,
or confused); and 4. focal neurological deficit(s) that may
or may not be transient [such as weakness, loss of balance,
and vision changes]. (p. 1)
In most cases, symptoms associated with mTBI resolve
within weeks or months; however, 7–33% of individuals who
experience mTBI report symptoms that persist past 3-months
postinjury (Belanger, Curtiss, Demery, Lebowitz, & Vander-
ploeg, 2005). These symptoms typically include headache,
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dizziness, memory problems, balance problems, and irritabil-
ity, and are collectively referred to as prolonged postconcussive
syndrome (PPCS; Brenner et al., 2010).
Rates of head injury in OEF/OIF are 16–21% higher than
those in World War II, Korea, and Vietnam wars (Owens et al.,
2008). This may be partially due to a rise in the use of im-
provised explosive devices, “devices placed or fabricated in an
improvised manner incorporating destructive, lethal, noxious,
pyrotechnic or incendiary chemicals, designed to destroy, dis-
figure, distract or harass . . . ” (pg. GL3) (U.S. Department of
Defense [DoD], 1998). Other likely contributors to high rates of
head injury are body armor improvements and rapidity of med-
ical evacuations, which improve the rate of survival after severe
injury (Owens et al., 2008). Multiple head injuries and/or loss of
consciousness increase the likelihood of developing both post-
traumatic stress disorder (PTSD) and PPCS (Schneiderman,
Braver, & Kang, 2008). mTBI has been named the “signature
injury” of OEF/OIF/OND (Independent Review Group, 2007),
and the U. S. Department of Veterans Affairs (VA) and DoD
have allocated significant resources toward examining the po-
tential impact of mTBI on the treatment of co-occurring condi-
tions.
Although most veterans do not experience long-term men-
tal health issues related to deployment, approximately 20%
do report problems, including PTSD, depression, and/or al-
cohol and substance misuse (Tanielian & Rand Corp., 2008).
PTSD is an anxiety disorder characterized by re-experiencing,
avoidance, and hyperarousal symptoms that develop after ex-
posure to a traumatic event (American Psychiatric Association
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[APA], 2000). PTSD is diagnosed in 10–20% of returning vet-
erans (Polusny et al., 2011); however, for those with mTBI,
rates of PTSD may be as high as 40% (Carlson et al., 2009;
Polusny et al., 2011). Controversy pervades discussion of these
co-occurring conditions, with disagreement regarding whether
they are independent problems or manifestations of a common
substrate (Hoge, Goldberg, & Castro, 2009). This controversy
stems from significant overlap in the symptom profile and health
outcomes of PTSD and mTBI (Brenner et al., 2010; Polusny
et al., 2011). Both are associated with fatigue, irritability, poor
sleep, and impaired concentration, attention, and memory. Data
from several studies, however, demonstrate that postconcussive
symptoms and psychosocial outcomes associated with mTBI
are largely attributable to PTSD symptoms rather than mTBI
itself (Hoge et al., 2008; Polusny et al., 2011; Schneiderman
et al., 2008). Regardless of the diathesis of these issues, the
fact that interventions shown to reduce PTSD symptoms are
available suggest that such treatment is a reasonable and valid
point of initial treatment for people who experienced mTBI and
continue to suffer symptoms of PTSD.
Cognitive–behavioral therapy (CBT) has emerged as a gold
standard treatment for PTSD, with extensive research support-
ing its efficacy (Bisson et al., 2007; Rauch, Eftekhari, & Ruzek,
2012). Prolonged exposure (PE; a form of CBT) shows efficacy
with both civilians (Powers, Halpern, Ferenschak, Gillihan, &
Foa, 2010) and veterans (Rauch et al., 2009; Schnurr et al.,
2007; Tuerk et al., 2011). Despite its proven efficacy for the
treatment of PTSD, some clinicians have concerns about using
PE for PTSD in patients with a history of mTBI. Hesitance
to use PE may be due to anecdotal concerns that loss of con-
sciousness during a TBI will interfere with memory encoding,
and thus preclude re-experiencing symptoms (Bryant, 2001;
Joseph & Masterson, 1999) or render treatments that rely on
narrative accounts of the trauma (such as PE) less effective
(Verfaellie, Amick, & Vasterling, 2012). This hesitancy may
also be due to a reasonable, but underexplored belief that cog-
nitive impairment from TBI might reduce the efficacy of CBT
(Elder, Mitsis, Ahlers, & Cristian, 2010; Otis, McGlinchey,
Vasterling, & Kerns, 2011). Some have also voiced concerns
that chronic pain, deficits in emotion regulation, or reduced im-
pulse control could reduce the effectiveness or limit engagement
in trauma-focused treatment by PTSD patients with a history
of mTBI (Bryant & Hopwood, 2006). Recent studies have be-
gun to investigate the efficacy of PE and cognitive processing
therapy (CPT; another form of CBT) for individuals with a his-
tory of mTBI (Chard, Schumm, McIlvain, Bailey, & Parkinson,
2011; Walter, Kiefer, & Chard, 2012; Wolf, Strom, Kehle, &
Eftekhari, 2012). No controlled studies of treatment for PTSD
in mTBI, however, have been published. This represents a criti-
cal gap given the importance of providing efficacious treatment
to individuals with PTSD who experienced mTBI.
In this study, we assessed the impact of PE for individuals
with and without a history of TBI. We examined the treatment
correlates of TBI in two different studies. In Study 1, we ex-
amined the clinical impact of PE through a chart review of a
clinical sample of 51 veterans who received PTSD treatment in
a Veterans Health Administration (VHA) PTSD clinic. In Study
2, we examined secondary data from a randomized controlled
trial of 22 VA patients randomly assigned to PE or present
centered therapy (PCT). Given the extensive overlap in symp-
tomatology and outcomes between PTSD and mTBI, as well as
the simplicity, flexibility, and individualized nature of PE, we
expected that PE would be helpful for individuals with PTSD,
and that the presence of mTBI would not impact the effect
of PE.
Study 1
Method
Participants and procedure. For Study 1, all patients were
diagnosed with PTSD and treated with PE in a VHA PTSD
clinic as part of routine clinical care in an urban VA Medical
Center (VAMC). No protocol-related exclusion criteria or in-
centives to participate in treatment were in place. These data
were collected with approval from the institutional review board
(IRB) for the VA Ann Arbor Healthcare System.
The sample consists of all veterans who began PE treatment
between October 24, 2005 and June 7, 2011 and completed the
PTSD Symptom Checklist in accordance with the therapy pro-
tocol, with veterans from Vietnam, OEF/OIF/OND, and other
eras represented. Patients were identified for treatment through
referrals from general mental health providers, case managers,
and primary care providers to the VHA PTSD clinic. Before
beginning PE, patients received comprehensive psychiatric as-
sessment with the Mini-International Neuropsychiatric Inter-
view (MINI; Sheehan et al., 1998), and were formally assessed
for a PTSD diagnosis with the Clinician Administered PTSD
Scale (CAPS; Blake, Weathers, Nagy, & Kaloupek, 1995).
Clinical interviews were performed by experienced masters-
or doctoral-level clinicians with extensive training in the CAPS
and MINI. Eleven patients (22%) were positive for a CPRS-
defined TBI. Nine of these 11 patients were classified as posi-
tive for TBI based on TBI consultation or service connection,
and two were classified via problem list. Mean age was 49.3
years, and 59% of patients were married. Four percent of pa-
tients were Black and 96% were White. Approximately 50%
had other medical conditions, 17% had comorbid substance use
disorders, and 64% comorbid psychiatric diagnoses. Thirty-
seven percent served in Vietnam, 33% in the Persian Gulf, 4%
in Afghanistan, and 28% in Iraq.
Therapist assignment was based on provider availability as
part of normal operating procedures of the outpatient specialty
PTSD clinic. Treatment occurred in standard clinic practice.
As such, treatment sessions were not coded for treatment fi-
delity. All treatment providers were licensed social workers or
psychologists practicing in a specialized PTSD clinic, or clin-
ical social work or psychology trainees working under close
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supervision with PTSD clinic providers. All had completed
specialized training in PE either through the VA rollout or
through training from the senior author (S.A.M.R.).
Prolonged exposure (Foa, Hembree, & Rothbaum, 2007)
consists of four major components: (a) psychoeducation re-
garding common reactions to trauma, rationale for treatment
and self-assessment; (b) repeated in vivo exposure to situations
avoided due to trauma-related distress; (c) repeated, prolonged
imaginal exposure to traumatic memories; and (d) emotional
processing of the exposures. PE is usually delivered in 8–15
weekly, 90-minute sessions. In the current study, the length of
treatment varied by patient and was informed by ongoing col-
laborative assessment within the context of normative clinical
procedures. Given the individualized nature of the standard PE
protocol, no modifications were made for individuals with a
history of mTBI.
Measures. The PTSD Checklist–Specific Version (PCL-
S; Weathers, Huska, & Keane, 1991) is a 17-item self-report
measure of PTSD symptoms based on DSM-IV criteria (APA,
2000). Scores on the PCL-S range from 17 to 85 with higher
scores reflecting greater PTSD severity. A score of 50 or above
indicates clinical PTSD, and a change of 10 points or more is
considered clinically significant (Monson et al., 2008). The in-
strument has good diagnostic efficiency (> .70) and high inter-
nal consistency (α= .94; Blanchard, Jones-Alexander, Buckley,
& Forneris, 1996). Cronbach’s α for this sample was .92.
In the current study, TBI was defined by the presence of
TBI designation in the computerized patient record system
(CPRS). Patients were assigned a value between 0 and 2 based
on whether any of the following were present: (a) screened
positive for TBI in CPRS and received follow-up formal TBI
consultation at dedicated TBI clinics, (b) service connected for
TBI/postconcussive syndrome, or (c) current CPRS problem
list includes TBI-related issues (headaches that are connected
to TBI in notes, cognitive impairment connected to TBI in notes,
etc.). If all were negative then the score was zero. If any one of
the three criteria was positive then the score was 1. If evidence
in CPRS indicated clearly more than mild TBI (i.e., penetrating
gunshot wound, etc.) then a score of 2 was documented; how-
ever, preliminary investigation indicated no overt differences
in PTSD symptoms or responses between those who scored 1
and those who scored 2. Accordingly, the levels were combined
due to a low number of veterans scoring 2. The result was a
binary measure (0, 1) indicating the presence or absence of data
documenting a potential TBI.
Data analyses. Repeated measures, dependent means t
tests were used to compare pre- and posttreatment effects on the
PCL for the entire intent-to-treat (ITT) sample and for the treat-
ment completers subsample. Statistically significant differences
were qualified using d-type effect sizes. In the current study,
treatment completers were defined as any patient attending at
least eight sessions of PE, with the exception that early termina-
tion (i.e., prior to Session 8) was not operationalized as attrition
if the patient had achieved at least a 50% reduction in PCL from
baseline. In addition to analyzing pre- and posttreatment differ-
ences with t tests, hierarchical linear modeling (HLM) was used
to analyze the intention-to-treat (ITT) longitudinal data and to
investigate the potential effect of mTBI status on treatment out-
comes and the slope of outcomes. HLM is a practical strategy
for analyzing effectiveness data because the method does not
assume fixed time points of measurement or equal numbers
of observations and missing data do not cause special prob-
lems (Raudenbush & Bryk, 2002). Specifically, in the current
study, HLM was used to investigate longitudinal PCL outcomes
(Level 1) nested within patients (Level 2) to assess overall treat-
ment response and response over time. Variance components
sigma squared (σ2) and tao (τ) were estimated and used to cal-
culate intraclass correlations. Statistically significant outcomes
were qualified using between- and within-R2-type effect sizes
in a manner consistent with recommended guidelines (Snijders
& Bosker, 1994). HLM analyses were conducted using HLM
software (Raudenbush, Bryk, Cheong, & Congdon, 2004), and
all other analyses were conducted using SPSS Statistics 19
(IBM Corporation, Armonk, NY).
Results
The average number of sessions for the total ITT sample was
10 (SD = 3.8) with 40 veterans (78%) meeting criteria as treat-
ment completers. The average number of sessions for treatment
completers was 12 (SD = 2.7). Eleven veterans (22%) did not
complete at least eight sessions and were classified as non-
completers; these patients were retained for analysis in the ITT
sample. Neither baseline PCL severity score nor TBI status
were predictors of treatment completion or number of sessions.
Baseline PCL-S scores were consistent with previous studies
with veteran samples (Schnurr et al., 2007; Tuerk et al., 2011).
Mean pre- and posttreatment PCL-S scores for the ITT sample
were 60 (SD = 13, range = 29–85) and 47 (SD = 17). This
difference is clinically and statistically significant, t(49) = 6.59,
p< .001, d = 1.00. Mean pre- and posttreatment PCL-S scores
for the treatment completer sample were 60.4 (SD = 13.4)
and 45.3 (SD = 16.5). This difference is also clinically and
statistically significant, t(39) = 7.19, p < .001, d = 1.13.
Considering the subsample of only those patients with mTBI,
mean pre- and posttreatment PCL-S scores for the ITT sample
were 58.9 (SD = 8.6) and 43.5 (SD = 14.1). This difference is
clinically and statistically significant, t(10) = 3.65, p < .005,
d = 1.81. Mean pre- and posttreatment PCL-S scores for the
treatment completer sample were 61.0 (SD = 7.7) and 44.0
(SD = 14.3). This difference is also clinically and statistically
significant, t(7) = 3.68, p < .01, d = 2.22.
Models of longitudinal PCL outcomes were based on
234 points of measurement (Level 1) nested within 51 pa-
tients (Level 2). The unconditional HLM model estimated vari-
ance components for Level-1 and Level-2 units (σ2 = 95.41,
τ = 152.85). The value of τ was significantly different from
zero, χ2(50) = 358.76, p < .001, indicating the presence of
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patient-level effects on outcomes. The intraclass correlation
(ICC) was .62, indicating that 62% of total PCL variance
could be accounted for by factors associated with the patient
(R2-between). Such factors could be related to personal charac-
teristics (i.e., age or baseline pathology) or external factors that
varied by patient (i.e., assigned therapist or seasonal effects).
The remaining variance (38%) could be attributed to within-
patient effects such as time in treatment or to other factors not
included in the model.
The next sequential step in modeling involved adding weeks
in treatment (i.e., occurrence of longitudinal measurement, or
“session dose”) as a Level-1 within-patient predictor. Weeks in
treatment significantly predicted PCL outcomes, σ2 = 60.71, τ
= 165.45, χ2(50) = 563.85, p < .001. The modeled coefficient
indicated linear decreases in PCL symptoms over time, t(232)
= 10.24, p < .001. The weeks in treatment effect accounted
for 9% of the variance in outcomes. Baseline PCL scores were
not a significant predictor of treatment outcomes or the slope
of outcomes.
With overall treatment effects accounted for, the next step
in the model involved adding TBI status to explore potential
disparities in outcomes. TBI status did not significantly predict
PCL scores, t(49) = −0.94, p = .35, or the slope of scores
over time, t(49) = −0.39, p = .70. Additionally, there were no
statistically significant differences in time spent in treatment
between groups, t(48) = −0.84, p = .31. Patients with and
without a history of TBI spent an average of 6.5 (SD = 4.0)
weeks and 5.5 (SD = 2.3) weeks in treatment, respectively. Ac-
cordingly, TBI status was omitted from the final parsimonious
model (Table 1).
Study 2
Method
Participants and procedures. The following analyses
were conducted as a post-hoc examination of data collected
in a translational treatment mechanisms study. As such, the
sample size is small and findings are preliminary. Due to small
sample size and the design of the primary study, only treatment
completers are included in the analyses. Treatment completion
was defined as finishing 10–12 sessions per protocol and com-
pleting the posttreatment assessment. (For a full description
of study procedures and the sample, see Rauch et al., 2013.)
All veterans participated in the treatment study between Jan-
uary 2008 and July 2010 (N = 22; 9% female, 23% African
American, 73% White, 5% Asian). Mean age was 32.7 years
(SD = 6.9). With regard to combat location, 81% served in
Iraq and 33% served in Afghanistan, with some veterans re-
porting deployments to both locations. The same definition for
TBI status was used as Study 1. Based on this definition, 36%
(n = 8) of the sample had experienced TBI (most mild, but
some with more severe injuries including a penetrating head
wound). No veterans were excluded due to cognitive impair-
ment. As reported in the primary outcome article, comorbidity
was representative of the OEF/OIF/OND population: 57% had
depression or dysthymia, 10% had alcohol abuse, and 29% met
criteria for another anxiety disorder at intake. All treatment
was conducted by an experienced PE provider (S.A.M.R.) with
over 12 years of experience using the protocol. All participants
provided written informed consent, and all procedures were
conducted with approval from the IRB for the VA Ann Arbor
Healthcare System.
All veterans were randomly assigned to receive between 10
to 12 sessions of PE or PCT (Schnurr et al., 2007) based on
clinical presentation at session 10. PCT uses a present-centered
and problem-solving oriented approach to facilitate adaptive
responses to ongoing stress and difficulties and assist the veteran
in obtaining his or her highest level of functioning.
Measure. The Clinician Administered PTSD Scale
(CAPS; Blake et al., 1995) is an interview measure of PTSD
severity with excellent psychometric properties, including high
internal consistency (α =.94; Blake et al., 1995). Cronbach’s α
for this sample was .95. Each of the 17 DSM-IV PTSD symp-
toms is rated on both frequency and intensity according to a
5-point (0–4) scale. These ratings are summed to compute a
severity score for each symptom, and the symptom scores are
summed to obtain an overall measure of PTSD severity.
Data analyses. We used repeated measures (pre-, mid-,
post-) analysis of variance (ANOVA) to compare the impact of
TBI (TBI vs. no TBI) on treatment effects for PTSD (CAPS).
To provide additional information regarding the impact of TBI
on treatment, planned follow-up repeated measures ANOVAs
among TBI positive veterans were also conducted to compare
the impact of treatment condition (PE vs. PCT) on CAPS. Given
the small sample size, planned comparisons that approached
significance and statistically significant differences were quali-
fied using d-type effect sizes. HLM was not deemed necessary
because this study employed fixed time points and did not have
missing data.
Results
As reported elsewhere (Rauch et al., 2013), CAPS scores in the
PE and PCT groups combined were significantly reduced over
time, F(2, 40) = 35.3, p < .001, pre- (M = 78.4, SD = 11.3),
posttreatment (M = 41.4, SD = 26.0), pre- to posttreatment d =
1.85. Neither the main effect of TBI status, F(1, 20) = 1.0, not
significant (ns), nor the interaction between time and TBI, F(2,
40) = 0.1, ns—approached significance. Moreover, the mean
pre- and post-CAPS scores between groups were very similar
(no-TBI pre-CAPS M = 76.1, SD = 10.8 and post-CAPS M
= 39.1, SD = 22.5; TBI pre-CAPS M = 82.4, SD = 11.7 and
post-CAPS M = 45.5, SD = 32.5).
Among the TBI group only (n = 8), CAPS scores were
significantly reduced over time, F(2 ,12) = 16.6, p< .001, pre-
treatment (M = 82.4, SD = 11.7), posttreatment (M = 45.5, SD
= 32.5), pre- to posttreatment d = 1.51. Further, the interaction
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Table 1
Hierarchical Linear Model of PTSD Checklist
Effect β SE or variance component 95% CI t or χ2
Fixed Effect
Intercept 54.42 1.90 [50.70, 58.14] 28.63∗
Weeks in treatment − 1.15 0.11 [ − 1.37, −0.93] − 10.24∗
Random Effect
Intercept (u0) 165.45 [140.26, 190.64] 563.85∗
Level 1 (r) 60.71 [45.43, 75.99]
Note. n = 50, df within = 233, df between = 50. PTSD = posttraumatic stress disorder; CI = confidence interval.
∗p < .001.
between treatment group and time was also significant, F(2 ,12)
= 5.4, p = .02. Follow-up planned t tests between treatment
groups at each time point revealed no difference at pretreatment
(PE, M = 82.8, SD = 15.3; PCT, M = 82.0, SD = 9.3, p = .70),
no difference at midtreatment (PE, M = 55.8, SD = 20.4; PCT,
M = 75.0, SD = 23.2, p = .15), and approaching significance
at posttreatment (p = .06, PE, M = 24.8, SD = 23.8, PE pre-
to posttreatment d = 2.9; PCT, M = 66.3, SD = 27.3, PCT pre-
to posttreatment d = 0.8).
Discussion
In this study, we investigated the utility of PE for individuals
with and without a history of TBI in a sample from a VHA PTSD
clinic and in a small sample from a randomized controlled trial
of PE versus PCT. As hypothesized, PE was highly efficacious
for individuals with PTSD, and there was no evidence to suggest
that the presence of TBI impacted the efficacy of PE. This is
the first investigation to demonstrate a lack of difference in
treatment trajectories from a direct comparison of PTSD plus
TBI to PTSD alone.
Our findings replicate and extend previous reports that PE is
effective for veterans with PTSD. Previous studies have demon-
strated the efficacy of PE with multiera veterans (Rauch et al.,
2009; Tuerk et al., 2011), female veterans (Schnurr et al., 2007),
older veterans (Thorp, Stein, Jeste, Patterson, & Wetherell,
2012), and via telehealth (Tuerk, Yoder, Ruggiero, Gros, &
Acierno, 2010). In our studies, PE demonstrated utility in a ran-
domized controlled trial comparing PE versus PCT (see Rauch
et al., 2013), as well as in a normative clinical sample of mixed
traumas presenting to a VHA PTSD clinic. The effect size for
PE was large (normative clinical sample, d = 1.13; among TBI
group in RCT, d = 2.9). These effect sizes are similar to prior
studies from our group (Rauch et al., 2009) and others (Schnurr
et al., 2007). These data provide additional support for PE’s
role as a first-line treatment for PTSD in veteran populations,
in accordance with the U.S. Department of Veterans Affairs &
Department of Defense (VA/DoD) Clinical Practice Guideline
(VA/DoD, 2010).
Our findings provide preliminary evidence that mTBI status,
which encompasses a broad range of severity of injuries, does
not contraindicate PE. Similarly, Wolf and colleagues (2012)
demonstrated a 45% post-PE reduction in PTSD symptoms in
10 veterans with PTSD plus mTBI. Our studies build on this
finding in a number of ways. First, we establish that PE was
helpful in a clinical sample of individuals both with and without
a history of TBI. Second, HLM allowed us to examine change
with both outcomes and slope of outcomes (i.e., trajectories
of change) to provide additional evidence that individuals with
PTSD plus TBI respond favorably to PE. Finally, our RCT
sample of PTSD plus TBI demonstrated a trend toward lower
posttreatment scores after PE than after PCT.
Some providers have voiced concerns that individuals with a
history of mTBI are more likely to experience cognitive impair-
ment and thus will not benefit from trauma-focused treatment
(Bryant & Hopwood, 2006; Elder et al., 2010; Otis et al., 2011).
Our data challenge these concerns. In addition, the finding that
PE is useful for individuals with a history of mTBI is consis-
tent with PE’s theorized mechanism of action. According to
emotion processing theory (Rauch & Foa, 2006), successful
treatment requires modification of a fear structure through (a)
activation of the fear structure, and (b) incorporation of incom-
patible corrective information into the fear structure (Foa &
Kozak, 1986). This is achieved through repeated exposure to
situations and memories that are feared, but objectively safe, to
facilitate habituation and extinction. Because these processes
depend heavily on limbic and medial prefrontal circuits that are
conserved across species (Quirk & Mueller, 2008), there is little
reason to believe that minor impacts on the brain would pre-
clude them. Indeed, PE’s emphasis on behavioral tasks makes it
amenable to populations with varying levels of cognitive func-
tioning, including children (Gilboa-Schechtman et al., 2010)
and older adults (Thorp et al., 2012). Of note, the most com-
monly reported sequelae of mTBI—headache, dizziness, irri-
tability, and memory problems (Terrio et al., 2009)—are equally
likely to be present in individuals with PTSD but without mTBI
(Brenner et al., 2010). Thus, it is unlikely that these physical
and cognitive symptoms might serve as a basis for producing
differential efficacy of PE in the PTSD with and without mTBI
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groups. In summary, PE may be well suited to those with a his-
tory of mTBI due to its simplicity, flexibility, and individualized
nature (Rauch et al., 2012).
There are several limitations to this study. Our sample
size was small, thus our results are not powered to address
noninferiority questions regarding detecting medium to small
PE-treatment differences that might exist between those with
and without a history of TBI. We did not assess current post-
concussive symptoms, only a history of TBI. Therefore, our
study addresses historical TBI status and not necessarily PPCS.
Some studies suggest PPCS is the mediating factor between
TBI and PTSD (Morissette et al., 2011). Thus, it is possible that
treating PPCS directly (through cognitive treatment, speech
therapy, occupational therapy, or physical therapy) could assist
in reduction of PTSD symptoms. However, mounting evidence
suggests that PTSD prolongs and exacerbates PPCS (Hoge
et al., 2008; Polusny et al., 2011); therefore, we believe that
addressing PTSD symptoms directly in individuals with PPCS
is warranted. To delineate this issue, future studies should
distinguish between individuals with a history of mTBI who
are currently experiencing PPCS versus individuals with a
history of mTBI with no current PPCS. Our findings suggest
that a history of mTBI does not preclude PE. A related issue is
that our classification of TBI relied on chart review. Although
all OEF/OIF/OND veterans were assessed for TBI via VHA
standard TBI screening and received follow-up formal TBI
consultation at dedicated TBI clinics, this stringent assessment
could not be performed for Vietnam era and Persian Gulf vet-
erans. Therefore, we relied on other means (service connection
for TBI-related conditions; CPRS problem list) for identifying
TBI among older veterans. This may have slightly impacted the
precision of TBI diagnosis among older veterans. Additionally,
level of cognitive function was not assessed in either study; as
such, we cannot comment on cognitive function in our groups.
However, the large treatment effect sizes in individuals with and
without a history of TBI indicate that differences in cognitive
functioning, if present, did not significantly impact treatment.
In conclusion, our study examined the impact of PE for in-
dividuals with and without a history of TBI, and found that
the presence of TBI did not contraindicate PE. Because PTSD
drives many psychosocial limitations in veterans with PTSD
and mTBI, effective PTSD treatment for this population is crit-
ical for clinical care. The current findings suggest that as long as
standard appropriate safety procedures are in place, treatment
providers should continue to offer PE for PTSD to veterans
with a history of mTBI, and to keep expectations for clinical
improvements high.
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